Jignesh Kantilal Parikh

Title: Jignesh Kantilal Parikh: Innovator in EGFR Inhibitors

Introduction

Jignesh Kantilal Parikh is a notable inventor based in Pune, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of EGFR inhibitors. With a total of 2 patents to his name, Parikh is recognized for his innovative approaches to treating abnormal cell growth in mammals.

Latest Patents

Parikh's latest patents include groundbreaking work on flavone-based EGFR inhibitors. This invention discloses a novel EGFR inhibitor compound and outlines a process for its preparation. The methods described aim to treat abnormal cell growth by administering specific compounds. Additionally, he has developed benzimidazole-based EGFR inhibitors, which also focus on treating abnormal cell growth through similar innovative methods.

Career Highlights

Jignesh Kantilal Parikh is affiliated with the Council of Scientific and Industrial Research, where he continues to advance his research in the field of pharmaceuticals. His work has garnered attention for its potential impact on cancer treatment and other related medical applications.

Collaborations

Parikh has collaborated with notable colleagues such as Pradeep Kumar and Eeshwaraiah Begari. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Jignesh Kantilal Parikh stands out as a significant figure in the realm of medicinal chemistry, particularly for his innovative work on EGFR inhibitors. His contributions are paving the way for advancements in cancer treatment and other medical fields.